Press release
Peptide Drug Discovery Market to Reach USD 5.3 Billion by 2034, Growing at 12% CAGR
Peptide Drug Discovery Market
Peptides - short chains of amino acids - bridge the gap between small molecules and large biologics, offering unique therapeutic potential. With high specificity, low toxicity, and excellent safety profiles, peptide-based drugs are emerging as powerful tools in oncology, metabolic diseases, infectious diseases, cardiovascular disorders, and rare conditions.
The peptide drug discovery market has gained momentum due to advances in synthetic chemistry, high-throughput screening, structure-based design, and peptide libraries. Supported by biotechnology growth, increasing collaborations, and rising demand for personalized medicine, the market is poised for robust expansion through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72926
Market Overview
• Market Size (2024): USD 1.7 billion (estimated)
• Forecast (2034): USD 5.3 billion
• CAGR (2024-2034): ~12.0%
Key Growth Drivers:
• Expanding pipeline of peptide-based therapeutics.
• Advantages of peptides over small molecules (specificity, reduced side effects).
• Rising demand for peptide libraries and custom synthesis services.
• Growing R&D investment in oncology, metabolic, and infectious diseases.
Challenges:
• Stability and short half-life issues of peptide drugs.
• Delivery challenges, especially for oral formulations.
• High R&D and synthesis costs.
Leading Companies:
Bachem Holding AG, Pepscan, PolyPeptide Group, Thermo Fisher Scientific, Creative Peptides, CordenPharma, Merck KGaA, Eli Lilly and Company, Sanofi, Amgen.
Segmentation Analysis
By Type
• Natural Peptides
• Synthetic Peptides
• Modified Peptides
By Technology
• High-Throughput Screening
• Structure-Based Drug Design
• Computational Modeling & AI-Based Discovery
• Peptide Library Synthesis
• Solid-Phase & Liquid-Phase Synthesis
By Therapeutic Area
• Oncology
• Metabolic Disorders (Diabetes, Obesity)
• Infectious Diseases
• Cardiovascular Diseases
• Neurology
• Autoimmune & Rare Diseases
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Diagnostic Centers
Summary:
Synthetic and modified peptides dominate due to scalability and therapeutic innovation. Oncology is the largest therapeutic application, followed by metabolic disorders, while infectious disease research saw accelerated momentum during the COVID-19 pandemic.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72926/peptide-drug-discovery-market
Regional Analysis
North America
• Largest market in 2024, supported by advanced peptide discovery platforms and strong biotech presence.
• NIH funding and FDA approvals drive innovation.
Europe
• Leading peptide R&D hubs in Germany, Switzerland, and the UK.
• Presence of global peptide CDMOs like Bachem and PolyPeptide Group.
Asia-Pacific
• Fastest-growing region (CAGR ~13%), driven by expanding biotech clusters in China, India, Japan, and South Korea.
• Increasing outsourcing for peptide libraries and drug discovery services.
Middle East & Africa
• Emerging market, limited by infrastructure but expanding clinical trials in GCC.
• Early adoption of peptide research in South Africa.
Latin America
• Brazil and Mexico driving demand through biotech collaborations and pharma outsourcing.
Summary:
While North America and Europe dominate, Asia-Pacific is emerging as the fastest-growing hub, offering cost-effective drug discovery services and expanding clinical research infrastructure.
Market Dynamics
Key Growth Drivers
• Increasing demand for novel peptide therapeutics in oncology and rare diseases.
• Growth of AI-driven and computational peptide drug design.
• Expanding role of CROs/CDMOs in peptide discovery outsourcing.
• Advances in delivery systems (nanoparticles, oral formulations).
Key Challenges
• Peptide instability and degradation challenges.
• Regulatory hurdles in peptide drug approvals.
• Cost and time-intensive clinical trials.
Latest Trends
• AI and machine learning accelerating peptide design.
• Development of cell-penetrating peptides for intracellular targets.
• Growing interest in personalized peptide-based vaccines.
• Expansion of green and sustainable chemistry methods in peptide synthesis.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72928
Competitor Analysis
Major Players:
• Bachem Holding AG
• Pepscan
• PolyPeptide Group
• Thermo Fisher Scientific
• Creative Peptides
• CordenPharma
• Merck KGaA
• Eli Lilly and Company
• Sanofi
• Amgen
Competitive Landscape:
The market is innovation-driven and fragmented, with players ranging from large pharma companies (Eli Lilly, Amgen, Sanofi) to specialized peptide firms (Bachem, PolyPeptide, Pepscan). Contract research and outsourcing are expanding, with CROs/CDMOs playing a vital role in custom peptide drug discovery. Partnerships and AI-driven platforms are accelerating development timelines.
Conclusion
The peptide drug discovery market is projected to grow from USD 1.7 billion in 2024 to USD 5.3 billion by 2034, at a CAGR of 12.0%. The combination of specificity, safety, and versatility positions peptides as key players in the future of therapeutics.
Despite challenges of stability, delivery, and regulatory hurdles, rapid progress in AI-driven discovery, peptide libraries, and advanced delivery technologies is driving innovation. With Asia-Pacific emerging as the fastest-growing region and oncology leading therapeutic adoption, peptide drug discovery will remain central to next-generation healthcare.
Key Takeaway: Companies that leverage AI-driven peptide design, scalable CDMO partnerships, and personalized peptide therapeutics will lead the market into its next phase of growth.
This report is also available in the following languages : Japanese (ペプチド創薬), Korean (펩타이드 약물 발견), Chinese (肽类药物研发), French (Découverte de médicaments peptidiques), German (Entdeckung peptidischer Arzneimittel), and Italian (Scoperta di farmaci peptidici), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72926
Our More Reports:
Lupus Drugs Clinical Trials
https://exactitudeconsultancy.com/reports/73164/lupus-drugs-clinical-trials-market
Ubiquitin Enzymes
https://exactitudeconsultancy.com/reports/73166/ubiquitin-enzymes-market
Dendritic Cell Cancer Vaccines
https://exactitudeconsultancy.com/reports/73168/dendritic-cell-cancer-vaccines-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Drug Discovery Market to Reach USD 5.3 Billion by 2034, Growing at 12% CAGR here
News-ID: 4205713 • Views: …
More Releases from Exactitude Consultancy
After H. pylori is eradicated, invasive gastric cancer patterns
Helicobacter pylori (H. pylori) infection is one of the most common chronic bacterial infections worldwide, affecting more than 50% of the global population. It is strongly linked to gastritis, peptic ulcers, and gastric cancer, making its effective diagnosis and treatment a critical public health priority.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72885
For decades, triple therapy (proton pump inhibitor + clarithromycin + amoxicillin/metronidazole) has been the gold standard. However,…
Coronavirus Preventive Vaccines Market to Reach USD 92.7 Billion by 2034, Growin …
Introduction
The COVID-19 pandemic reshaped global healthcare, placing coronavirus preventive vaccines at the center of scientific, political, and public health efforts. Within record time, multiple vaccines were developed, authorized, and distributed globally, saving millions of lives.
While the emergency phase of the pandemic has passed, the coronavirus preventive vaccines market continues to evolve, driven by the need for booster programs, variant-targeted vaccines, pan-coronavirus research, and preparedness for future outbreaks. With mRNA, viral…
Non-Viral Drug Delivery Systems Market to Reach USD 41.2 Billion by 2034
Non-viral drug delivery systems are rapidly emerging as a cornerstone of modern medicine, offering safe and effective alternatives to viral vectors for transporting therapeutic agents such as nucleic acids, proteins, peptides, and small molecules. These systems include lipid nanoparticles (LNPs), polymers, exosomes, dendrimers, and physical methods like electroporation, which have demonstrated significant potential in gene therapy, oncology, vaccines, and regenerative medicine.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72887
The…
Antibody Purification Services Market to Reach USD 4.59 Billion by 2034
Antibody purification is a critical process in the production of biologics, therapeutic antibodies, diagnostic reagents, and research tools. It involves the isolation of antibodies from complex mixtures, ensuring high purity, stability, and functionality for downstream applications. With the rising demand for monoclonal antibodies, biosimilars, and antibody-based diagnostics, contract purification services are becoming essential for pharmaceutical, biotechnology, and research institutions.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72889
Advances in chromatography…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
